5 Matching Annotations
  1. Feb 2022
  2. twitter.com twitter.com
    Deepti Gurdasani on Twitter
    1
    1. lucyparfitt16 02 Feb 2022

      Deepti Gurdasani. (2022, January 29). Going to say this again because it’s important. Case-control studies to determine prevalence of long COVID are completely flawed science, but are often presented as being scientifically robust. This is not how we can define clinical syndromes or their prevalence! A thread. [Tweet]. @dgurdasani1. https://twitter.com/dgurdasani1/status/1487366920508694529

      is:tweet lang:en COVID-19 case-control studies prevalence research bad science robustness syndrome long covid clinical history scientific method flawed science
    Visit annotations in context

    Tags

    Annotators

    URL

    twitter.com/dgurdasani1/status/1487366920508694529
  3. Jan 2022
  4. www.nejm.org www.nejm.org
    Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents | NEJM
    1
    1. lucyparfitt16 13 Jan 2022

      Olson, S. M., Newhams, M. M., Halasa, N. B., Price, A. M., Boom, J. A., Sahni, L. C., Pannaraj, P. S., Irby, K., Walker, T. C., Schwartz, S. P., Maddux, A. B., Mack, E. H., Bradford, T. T., Schuster, J. E., Nofziger, R. A., Cameron, M. A., Chiotos, K., Cullimore, M. L., Gertz, S. J., … Randolph, A. G. (2022). Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMoa2117995

      is:article lang:en COVID-19 vaccine hospitalization paediatric hospitalization USA real-world data adolescents children case-control studies vaccine effectiveness ICU mortality dose research
    Visit annotations in context

    Tags

    Annotators

    URL

    nejm.org/doi/full/10.1056/NEJMoa2117995
  5. Dec 2021
  6. www.thelancet.com www.thelancet.com
    Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses
    1
    1. lucyparfitt16 01 Dec 2021

      Thiruvengadam, R., Awasthi, A., Medigeshi, G., Bhattacharya, S., Mani, S., Sivasubbu, S., Shrivastava, T., Samal, S., Rathna Murugesan, D., Koundinya Desiraju, B., Kshetrapal, P., Pandey, R., Scaria, V., Kumar Malik, P., Taneja, J., Binayke, A., Vohra, T., Zaheer, A., Rathore, D., … Garg, P. K. (2021). Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: A test-negative, case-control study and a mechanistic study of post-vaccination immune responses. The Lancet Infectious Diseases, S1473309921006800. https://doi.org/10.1016/S1473-3099(21)00680-0

      is:pdf lang:en COVID-19 vaccine delta variant India immune response case-control studies vaccine effectiveness transmissibility protection waning immunity
    Visit annotations in context

    Tags

    Annotators

    URL

    thelancet.com/action/showPdf
  7. Nov 2021
  8. www.thelancet.com www.thelancet.com
    COVID-19 vaccines in the age of the delta variant
    1
    1. lucyparfitt16 27 Nov 2021

      Wheatley, A. K., & Juno, J. A. (2021). COVID-19 vaccines in the age of the delta variant. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00688-5

      is:article lang:en COVID-19 vaccine delta variant effectiveness viral evolution first-generation variant of concern VOC protection immunity case-control studies vaccine efficacy transmission mortality immune response breakthrough infection data booster
    Visit annotations in context

    Tags

    Annotators

    URL

    thelancet.com/journals/laninf/article/PIIS1473-3099(21)00688-5/fulltext
  9. www.thelancet.com www.thelancet.com
    Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses
    1
    1. lucyparfitt16 27 Nov 2021

      Thiruvengadam, R., Awasthi, A., Medigeshi, G., Bhattacharya, S., Mani, S., Sivasubbu, S., Shrivastava, T., Samal, S., Murugesan, D. R., Desiraju, B. K., Kshetrapal, P., Pandey, R., Scaria, V., Malik, P. K., Taneja, J., Binayke, A., Vohra, T., Zaheer, A., Rathore, D., … Garg, P. K. (2021). Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: A test-negative, case-control study and a mechanistic study of post-vaccination immune responses. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00680-0

      is:article lang:en COVID-19 vaccine variant of concern VOC vaccine effectiveness delta immune response case-control studies dose transmissibility protection waning immunity
    Visit annotations in context

    Tags

    Annotators

    URL

    thelancet.com/journals/laninf/article/PIIS1473-3099(21)00680-0/fulltext